Effects of SQ 27,427, a thromboxane A2 receptor antagonist, in the human platelet and isolated smooth muscle
- 1 August 1984
- journal article
- research article
- Published by Elsevier in European Journal of Pharmacology
- Vol. 103 (1-2), 9-18
- https://doi.org/10.1016/0014-2999(84)90183-3
Abstract
No abstract availableKeywords
This publication has 25 references indexed in Scilit:
- Thromboxane A2 mediated bronchoconstriction in the anesthetized guinea pigEuropean Journal of Pharmacology, 1982
- INHIBITION OF THROMBOXANE SYNTHETASE DOES NOT NECESSARILY PREVENT PLATELET AGGREGATIONThe Lancet, 1981
- Circulatory and platelet actions of 6,9-Thiaprostacyclin (PGI2-S) in the catLife Sciences, 1979
- Platelet and Blood Vessel Arachidonate Metabolism and InteractionsJCI Insight, 1979
- Diversion of prostaglandin endoperoxide metabolism by selective inhibition of thromboxane A2 biosynthesis in lung, spleen or plateletsEuropean Journal of Pharmacology, 1977
- An enzyme isolated from arteries transforms prostaglandin endoperoxides to an unstable substance that inhibits platelet aggregationNature, 1976
- Effect of substrate concentration on inhibition of prostaglandin synthetase of bull seminal vesicles by anti-inflammatory drugs and fenamic acid analogsBiochimica et Biophysica Acta (BBA) - Lipids and Lipid Metabolism, 1976
- Release of Additional Factors in Anaphylaxis and its Antagonism by Anti-inflammatory DrugsNature, 1969
- Aggregation of Blood Platelets by Adenosine Diphosphate and its ReversalNature, 1962
- The tracheal strip: Observations on the response of tracheal muscleJournal of Allergy, 1958